Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuropsychopharmacology

• Publication date

  2005-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.npp.1300622PMID 15562293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treating Tobacco Use and Dependence

  2008cited by this paper
• Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.

  2005cited by this paper
• Antidepressant effects of pramipexole, a novel dopamine receptor agonist

  2005cited by this paper
• Nicotine induces conditioned place preferences over a large range of doses in rats

  2005influential reference
• The tail suspension test: A new method for screening antidepressants in mice

  2004cited by this paper
• Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice

  2004cited by this paper
• Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference

  2004cited by this paper
• Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences

  2004cited by this paper
• Development of Novel 1,2,3,4‐Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands

  2004cited by this paper
• Selective Antagonism at Dopamine D3 Receptors Prevents Nicotine-Triggered Relapse to Nicotine-Seeking Behavior

  2003cited by this paper
• Disruption of nicotine conditioning by dopamine D3 receptor ligands

  2003influential reference
• Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

  2003cited by this paper
• Anxiolytic-like effects of preferential dopamine D3 receptor agonists in an animal model.

  2003cited by this paper
• Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference

  2003cited by this paper
• Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A

  2003cited by this paper
• The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.

  2003cited by this paper
• Effects of a Dopamine D3 Receptor Ligand, BP 897, on Acquisition and Expression of Food-, Morphine-, and Cocaine-induced Conditioned Place Preference, and Food-seeking Behavior in Rats

  2003cited by this paper
• Subsecond dopamine release promotes cocaine seeking

  2003cited by this paper
• Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.

  2003cited by this paper
• Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats

  2003influential reference
• Acute administration of the selective D3 receptor antagonist SB‐277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats

  2003cited by this paper
• Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats

  2003cited by this paper
• Nicotine-like discriminative stimulus effects of bupropion in rats.

  2002cited by this paper
• Environmental stimuli promote the acquisition of nicotine self-administration in rats

  2002cited by this paper
• Importance of nonpharmacological factors in nicotine self-administration.

  2002cited by this paper
• Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice

  2002influential reference
• Dopamine D3 Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats

  2002cited by this paper
• Pramipexole in treatment-resistant depression: a 16-week naturalistic study.

  2002cited by this paper
• Caffeine potentiates the discriminative-stimulus effects of nicotine in rats

  2002influential reference
• Nicotine and bupropion share a similar discriminative stimulus effect.

  2002cited by this paper
• Pramipexole for depression.

  2002cited by this paper
• Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

  2001cited by this paper
• Cue dependency of nicotine self-administration and smoking.

  2001cited by this paper
• Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens.

  2000cited by this paper
• Dopamine D3 Receptors Expressed by All Mesencephalic Dopamine Neurons

  2000influential reference
• Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments

  2000cited by this paper
• Dopamine D3 receptor agents as potential new medications for drug addiction

  2000cited by this paper
• Dissociation in Conditioned Dopamine Release in the Nucleus Accumbens Core and Shell in Response to Cocaine Cues and during Cocaine-Seeking Behavior in Rats

  2000cited by this paper
• Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.

  2000cited by this paper
• Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

  1999cited by this paper
• Limbic activation during cue-induced cocaine craving.

  1999cited by this paper
• The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d‐amphetamine or cocaine

  1998cited by this paper
• Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self‐administration or yoked‐administration of d‐amphetamine

  1998cited by this paper
• Drug discrimination in neurobiology.

  1998cited by this paper
• The D3 dopamine receptor: neurobiology and potential clinical relevance.

  1997cited by this paper
• Nicotine activates and desensitizes midbrain dopamine neurons

  1997cited by this paper
• The mesolimbic dopamine system as a target for rapid antidepressant action

  1997cited by this paper
• Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.

  1997cited by this paper
• Discriminative stimulus effects of nicotine and chronic tolerance.

  1997influential reference
• Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus

  1996cited by this paper
• Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities

  1996cited by this paper
• A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

  1996cited by this paper
• Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

  1995influential reference
• Nicotine place preference using the biased method of conditioning.

  1994cited by this paper
• Amphetamine‐like effect of l‐deprenyl (selegiline) in drug discrimination studies *

  1994influential reference
• The neural basis of drug craving: an incentive-sensitization theory of addiction.

  1993cited by this paper
• Dopamine, addiction and reward

  1992influential reference
• Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

  1991cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Brain dopamine and reward.

  1989cited by this paper
• SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

  1989cited by this paper
• Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.

  1986cited by this paper
• Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants.

  1984cited by this paper
• Persistent behavior at high rates maintained by intravenous self-administration of nicotine.

  1981cited by this paper
• Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration.

  1981cited by this paper
• Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.

  1980cited by this paper
• Behavioural despair in rats: a new model sensitive to antidepressant treatments.

  1978cited by this paper
• Behavioral despair in mice: a primary screening test for antidepressants.

  1977cited by this paper
• Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey.

  1973cited by this paper
• The Conditioned Reinforcing Effects of Stimuli Associated with Morphine Reinforcement

  1968cited by this paper

• Roles of metabotropic signaling of nicotine receptors in the development and maintenance of nicotine reward through regulation of dopamine D3 receptor expression

  2024cites this paper
• A Historical Perspective on the Dopamine D3 Receptor.

  2022cites this paper
• The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature.

  2022cites this paper
• The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats.

  2022cites this paper
• Dopamine D3 receptor ligands: a patent review (2014–2020)

  2022cites this paper
• Effects of chronic nicotine exposure on Δ9-tetrahydrocannabinol-induced locomotor activity and neural activation in male and female adolescent and adult rats.

  2020cites this paper
• Chronic nicotine exposure attenuates the effects of Δ9‐tetrahydrocannabinol on anxiety‐related behavior and social interaction in adult male and female rats

  2019cites this paper
• α4β2 nicotinic acetylcholine receptor downregulates D3 dopamine receptor expression through protein kinase C activation.

  2019cites this paper
• Heterómeros de receptores de dopamina d1 y de histamina h3 como potenciales dianas terapéuticas en trastornos adictivos y enfermedades neurodegenerativas

  2018cites this paper
• SHANK3 downregulation in the VTA accelerates the extinction of contextual associations induced by non-familiar conspecific interaction

  2018cites this paper
• SHANK3 Downregulation in the Ventral Tegmental Area Accelerates the Extinction of Contextual Associations Induced by Juvenile Non-familiar Conspecific Interaction

  2018cites this paper
• Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder.

  2018cites this paper
• Dopamine D1 and D3 Receptor Polypharmacology in Cocaine Reward and Cocaine Seeking

  2017cites this paper
• Tiapride prevents the aversive but not the rewarding effect induced by parabrachial electrical stimulation in a place preference task.

  2017cites this paper
• Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.

  2017cites this paper
• The dopamine D3 receptor, a quarter century later

  2017cites this paper
• Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.

  2016cites this paper
• Targeting the dopamine D3 receptor: an overview of drug design strategies

  2016cites this paper
• Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.

  2016cites this paper
• The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders.

  2015cites this paper
• Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self‐administration in rhesus monkeys

  2015cites this paper
• Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.

  2014cites this paper
• Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice

  2014cites this paper
• Elevation of Dopamine Induced by Cigarette Smoking: Novel Insights from a [11C]-(+)-PHNO PET Study in Humans

  2014cites this paper
• Dopamine D3 receptors as a therapeutic target for methamphetamine dependence

  2014cites this paper
• Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development

  2014cites this paper
• Dopamine D3 Receptors in the Basolateral Amygdala and the Lateral Habenula Modulate Cue-Induced Reinstatement of Nicotine Seeking

  2014cites this paper
• Peroxisome proliferator-activated nuclear receptors and drug addiction

  2013cites this paper
• Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration

  2013cites this paper
• Cocaine Self-Administration in Dopamine D 3 Receptor Knockout Mice

  2013cites this paper
• Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil

  2013cites this paper
• The dopamine D 3 receptor as a therapeutic target for MA dependence : preclinical studies

  2013cites this paper
• endoCANNABINOIDS

  2013cites this paper
• Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence

  2013cites this paper
• Role of the Cannabinoid System in Modulating the Reinforcing and Relapse Related Properties of Nicotine in Rats

  2013cites this paper
• Cocaine self-administration in dopamine D₃ receptor knockout mice.

  2012cites this paper
• Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.

  2012cites this paper
• Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking

  2012cites this paper
• Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.

  2012cites this paper
• The Role of the Dopamine D, Receptors in Cue-induced Reinstatement of Nicotine-seeking Behaviour

  2011cites this paper
• PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats

  2011cites this paper
• Roles of BDNF, dopamine D(3) receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization.

  2011cites this paper
• Critical appraisal of the existing and emerging therapies for smoking cessation.

  2011cites this paper
• Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.

  2011cites this paper
• Pharmacotherapy for smoking cessation: present and future.

  2011cites this paper
• PRECLINICAL STUDY: FULL ARTICLE: The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended‐access

  2010cites this paper
• New horizons for therapeutics in drug and alcohol abuse.

  2010cites this paper
• Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia

  2010influential citation
• The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking.

  2010cites this paper
• Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors.

  2010cites this paper
• Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors

  2010cites this paper
• Dopamine Receptors and Behavior: From Psychopharmacology to Mutant Models

  2010cites this paper
• The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys

  2009cites this paper
• Neuropharmacology of the interoceptive stimulus properties of nicotine.

  2009cites this paper
• Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.

  2009cites this paper
• Evidence for the role of the dopamine D3 receptor in mediating methamphetamine addiction

  2009cites this paper
• Effects of nicotine in experimental animals and humans: an update on addictive properties.

  2009cites this paper
• Pharmacotherapy for tobacco dependence.

  2009cites this paper
• Molecular mechanisms underlying the motivational effects of nicotine.

  2009cites this paper
• Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.

  2009cites this paper
• Mechanism-based medication development for the treatment of nicotine dependence

  2009cites this paper
• Genetics of dopamine receptors and drug addiction: a comprehensive review

  2009influential citation
• Quels futurs traitements pour la dépendance au tabac et au cannabis

  2008cites this paper
• Dopaminergic mechanism of reward-related incentive learning: Focus on the dopamine d3 receptor

  2008cites this paper
• Genetics of nicotine dependence and pharmacotherapy.

  2008cites this paper
• Methylphenidate Enhances the Abuse-Related Behavioral Effects of Nicotine in Rats: Intravenous Self-Administration, Drug Discrimination, and Locomotor Cross-Sensitization

  2008cites this paper
• Nicotine and methamphetamine share discriminative stimulus effects.

  2008cites this paper
• Topiramate does not alter nicotine or cocaine discrimination in rats

  2008cites this paper
• Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats.

  2008cites this paper
• N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity

  2008cites this paper
• Conditioned Place Preference Induced by Licit Drugs: Establishment, Extinction, and Reinstatement

  2008cites this paper
• Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists.

  2008cites this paper
• Role of dopamine D3 receptors in the expression of conditioned fear in rats.

  2008cites this paper
• Pharmacotherapy of Methamphetamine Addiction: An Update

  2008cites this paper
• Nicotine place preference in a biased conditioned place preference design.

  2008cites this paper
• [Future medications for tobacco and cannabis dependence].

  2008cites this paper
• Sex Differences in Nicotine-Conditioned Hyperactivity in a Model of Dopamine D2 Receptor Priming: Roles of Dopamine D2 and D3 Receptor Subtypes.

  2008cites this paper
• Non-nicotinic therapies for smoking cessation.

  2007cites this paper
• Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus.

  2007cites this paper
• N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands

  2007cites this paper
• High Reinforcing Efficacy of Nicotine in Non-Human Primates

  2007cites this paper
• DOUBLE DISSOCIATION OF THE EFFECTS OF HALOPERIDOL AND THE DOPAMINE D 3 RECEPTOR-SPECIFIC ANTAGONIST ABT-127 ON ACQUISITION VS . EXPRESSION OF COCAINE CONDITIONED ACTIVITY

  2007cites this paper
• Overview of the pharmacogenomics of cigarette smoking

  2007cites this paper
• REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

  2007cites this paper
• Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors

  2007cites this paper
• Neurochemistry of Nicotine Dependence

  2007cites this paper
• Dopamine D3 receptor ligands for the treatment of tobacco dependence

  2007influential citation
• GENETIC STUDY: Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene–gene interactions associated with smoking‐related behaviors

  2007cites this paper
• Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.

  2007cites this paper
• Effets motivationnels de la nicotine chez le rat. Implication des endocannabinoïdes et d'autres systèmes de neurotransmission.

  2007cites this paper
• Targeting the Dopamine D 3 Receptor for Treatment of Nicotine Dependence

  2006cites this paper
• Neuropharmacology and potential efficacy of new treatments for tobacco dependence

  2006cites this paper
• Effect of the 5-HT(6) serotonin antagonist MS-245 on the actions of (-)nicotine.

  2006cites this paper
• Different lengths of times for progressions in adolescent substance involvement.

  2006cites this paper
• The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

  2006influential citation
• Treatment of Nicotine Dependence: Toward a Partial Solution

  2006cites this paper
• Pharmacotherapy of smoking cessation and the Indian scenario

  2006cites this paper
• Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition

  2006cites this paper
• De la neurobiología de la adicción a la nicotina al tratamiento del tabaquismo. Progresos terapéuticos

  2006cites this paper
• Tratamientos actuales del tabaquismo: revisión. Necesidades de nuevas vías de abordaje

  2006cites this paper